SYRE compared with ORKA: revenue, margins and what each company keeps, and the suppliers and customers both name

SYRESpyre Therapeutics, Inc.

Mkt capRevenueRevenue

ORKAOruka Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SYRESpyre Therapeutics, Inc.

ORKAOruka Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SYRE

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±13.8%▼−0.56%×0.04

Q1 FY26±8.3%▲+2.72%×0.33

Feb 20 '26±12.0%▲+14.28%×1.19

Nov 5 '25±21.2%▼−0.57%×0.03

ORKA

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.7%▲+6.40%×0.44

Q1 FY26±11.0%▼−8.52%×0.77

= impliedSYRE realized, solidORKA realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedspan: SYRE 273d · ORKA 738dSource: market data

Sep 6 '24

—

▲+2.80%

—

Aug 2 '24—▲+5.07%—

SYRESpyre Therapeutics, Inc.

96.44▼−2.55%

Mkt cap$8.5B

ORKAOruka Therapeutics, Inc.

96.24▼−0.42%· post 98.76

ClosedOct 30 '26

Mkt cap$6.4B

Compare

ClosedOct 30 '26

SYRESpyre Therapeutics, Inc.

ORKAOruka Therapeutics, Inc.

96.44▼−2.55%

Price

96.24▼−0.42%post 98.76

$8.5B

Mkt cap

$6.4B

SYRE96.44▼−2.55%vsORKA96.24▼−0.42%ClosedOct 30 '26